Bonjela (Choline salicylate with cetalkonium chloride): Discontinuation

Discontinuation Active

Bonjela will no longer being funded by Pharmac from 1 July 2024.

Affected product

Pharmac has decided to stop the partial funding of this product, this decision was prompted by regulatory changes. We note that funded Bonjela has not been available since mid-2023. We have received clinical advice that supports this decision.

  • Brand: Bonjela
  • Chemical: Choline salicylate with cetalkonium chloride
  • Pharmacode: 771473
  • Subsidy: $2.06 ($6.00)
  • Measure / Qty: per 15 g OP

People can still buy Bonjela from pharmacies, talk to your pharmacist about whether it is right for you or your whānau.  

Alternative products

A number of other funded alternatives remain listed in the Schedule to treat mouth ulcers. 

Schedule listings for agents used in mouth ulceration(external link)

HML Online listings for agents used in mouth ulceration(external link)

More information about funded and unfunded alternatives is available in the NZ Formulary.

Drugs for oral ulceration and inflammation - NZ Formulary(external link)

Delisting date 1 July 2024

Bonjela will be removed from both the Community Schedule and the Hospital Medicines List from 1 July 2024.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)